-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Neurocrine Biosciences, Maintains $204 Price Target

Benzinga·10/16/2026 11:08:08
Listen to the news
Needham analyst Ami Fadia reiterates Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and maintains $204 price target.